Journal
CANCER LETTERS
Volume 361, Issue 1, Pages 33-38Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2015.02.020
Keywords
Fanconi anemia; Oxidative stress; NF-kappa B; ROMO1; Mitochondrial dysfunction; EMT
Categories
Funding
- Council of Scientific and Industrial Research (CSIR) [09/084(0470)/2009-EMR-1]
Ask authors/readers for more resources
Fanconi anemia (FA) is a rare genetic disorder associated with a bone-marrow failure, genome instability, hypersensitivity to DNA crosslinking agents and a predisposition to cancer. Mutations have been documented in 16 FA genes that participate in the FA-BRCA DNA repair pathway, a fundamental pathway in the development of the disease and the presentation of its symptoms. Besides the well-established role of FA genes in DNA damage and repair pathways, recent reports have revealed an overproduction of epithelial to mesenchymal transition (EMT) factors via a NF-kappa B-dependent mechanism that results in the proliferation of neighboring tumor cells and FA cells have also been shown to possess damaged mitochondria, accompanied by altered RedOx pathways. This study has focused on reactive oxygen species Modulator-1 (ROMO1), an oncomarker and mitochondria] membrane protein, which is known to be associated with cancer growth and in the modulation of RedOx states in some cancer models. Here, we reveal the role of ROMO1 and demonstrate its link in regulating RedOx states and in the activation of NF-kappa B-dependent EMT factors in FA. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available